Research
The Department of Urology's research program ranks #3 among all urology departments in the country in National Institutes of Health funding. Multi-dimensional, interactive and highly transformative research programs provide the foundation for the Department's strong research standing.
Richly diverse, these programs include basic science research programs in angiogenesis, bioengineering, benign prostate diseases, prostate cancer, chronic pelvic pain, nanotechnology, sexual dysfunction, genetics, infertility, renal cancer, urinary tract infections and clinical outcomes research.
Faculty leading these research programs are listed below.
 Earl Cheng, MD
Tissue Engineering and Bladder Physiology
|
 Brian Helfand, MD, PhD
Prostate Cancer Cell Biology and Genetics
|
 David J. Klumpp, PhD
Bladder Biology, Pathogenesis, and Pelvic Pain
|
 Chung Lee, PhD
Prostate Ductal System; TGF-beta-based Gene Therapy in Cancer; Apoptosis in Prostate Cancer Cells
|
 Carol Podlasek, PhD
Sexual Dysfunction and Urogenital Development
|
 Charles N. Rudick, PhD
Transition from Acute Pain to Chronic Pain, Urinary Tract Pain
|
 Anthony J. Schaeffer, MD
Molecular Mechanisms of Urinary Tract Infection (UTI); Chronic Pelvic Pain
|
 C. Shad Thaxton, MD, PhD
Translational Bio-Nanotechnology
|
 Praveen Thumbikat, PhD
Benign Prostate Diseases, Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
 Olga Volpert, PhD
Tumor Angiogenesis and Molecular Mechanisms of Action of the Naturally Occurring Inhibitors of Angiogenesis
|
